Product List     API & Intermediate     

Circulatory System Drugs

Find
103
related chemicals for you
CAS:76547-98-3
Molecular Formula:C21H31N3O5
(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]-1-Oxohexyl]-2-Pyrrolidinecarboxylic acid;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenyl-Propyl]Amino]Hexanoyl]Proline;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenyl-Propyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Lisinopril; (2S)-1-[(2S)-6-Amino-2-[[(2S)-1-Hydroxy-1-oxo-4-Phenylbutan-2-yl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Amino-2-{[(1S)-1-Carboxy-3-Phenylpropyl]Amino}Hexanoyl]-2-Pyrrolidinecarboxylic acid; (2S)-1-[(2S)-6-Amino-2-{[(1S)-1-Carboxy-3-Phenylpropyl]Amino}Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Azanyl-2-[[(2S)-1-Oxidanyl-1-Oxidanylidene-4-Phenyl-Butan-2-yl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Hydrate; (S)-1-((S)-6-Amino-2-(((S)-1-Carboxy-3-Phenylpropyl)Amino)Hexanoyl)Pyrrolidine-2-Carboxylic acid; (S)-1-((S)-6-Amino-2-((S)-1-Carboxy-3-Phenylpropylamino)Hexanoyl)Pyrrolidine-2-Carboxylic acid; (S)-1-(N(2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-(N(sup 2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-[(S)-6-Amino-2-((S)-1-Carboxy-3-Phenyl-Propylamino)-Hexanoyl]-Pyrrolidine-2-Carboxylic ACID; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline Dihydrate; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-Lysyl-Proline Dihydrate; (S)-Lisinopril Dihydrate; [N2-[(S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; 1-[Nalpha-[(S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl]-L-Proline; 1-{N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl}-L-Prolin; Acerbon; Acercomp; Alapril; Amicor; Carace; Cipral; Coric; Diroton; Doneka; Hipril; Inhibril; Inopril; Irumed; Laaven; Linopril; Linvas; Lipril; Lisinal; Lisinopril Anhydrous; Lisinoprilum; Lisipril; Lisiprilprinivil; Lisitec; Lisopril; Lisoril; Lispril; Listril; Lizinopril; Lizonoton; Longes; Loril; LPR; L-Proline, 1-(N(sup 2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-, (S)-; L-Proline, 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-; L-Proline, 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-, (S)-; L-Proline, N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-; L-Proline, N2-((1S)-1-Carboxy-3-Phenylpropyl)-L-Lysyl-; Lysinopril; Lysinopryl; mk522; N-(1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl-L-Proline; N(2)-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Prolinato; N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; N-[N2 (1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; N-[N2 -(1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; n-{n-[(s)-1-Carboxy-3-Phenylpropyl]-l-Lysyl}-l-Proline; N2-((S)-1-Carboxy-3-Phenylpropyl)-L-Lysyl-L-Proline; N2-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; Nanopril; Noperten; Novatec; Optimon; Presiten; Prinil; Prinivil; Prinvil; Qbrelis; Renacor; Sinopril; Sinopryl; Skopryl; Tensopril; Tensyn; Tersif; Vitopril; Vivatec; Zestril
Brief Introduction
Lisinopril is mainly used as an antihypertensive drug of angiotensin converting enzyme inhibitors (ACEI).
CAS:90131-68-3
Molecular Formula:C10H21N3O9
Tribulusterristrisextract; Puncturevine Caltrop Fruit Extract; Tribulus Terrestris Saponins; 2-[Carbamimidoyl(Methyl)Amino]Acetic Acid; 2,3,4,5,6-Pentahydroxyhexanoic Acid; Caltrop; Goathead; Gokshura; Tribulus; Puncture Vine; Bulgarian Tribulus
CAS:959-24-0
Molecular Formula:C12H21ClN2O3S
Sotalol HCL; Betapace; Betapace AF; Sotalex; Sotacor; Sorine; MJ 1999; Sotalol (Hydrochloride); Sotylize; Berlex; Darob; Mead Johnson 1999; Sotalol.HCl; Sotalol, HCl; (+/-)-Sotalol Hydrochloride; Betapace (TN); Sotalol (Betapace); Sotalol Monohydrochloride; 4'-(1-Hydroxy-2-(Isopropylamino)Ethyl)Methanesulfonanilide Monohydrochloride; Isopropylaminohydroxyethylmethanesulfonanilide Hydrochloride; N-[4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide;Hydrochloride; N-Isopropyl-beta-(4-Methanesulfonamidophenyl)Ethanolamine Hydrochloride; 4-(2-Isopropylamino-1-Hydroxyaethyl)Methanesulfonailid Hydrochlorid; 4'-(1-Hydroxy-2-Isopropylaminoethyl)Methanesulphonanilide Hydrochloride; N-[4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; 4-(2-Isopropylamino-1-Hydroxyaethyl)Methanesulfonailid Hydrochlorid [German]; N-(4-(1-Hydroxy-2-(Isopropylamino)Ethyl)Phenyl)Methanesulfonamide Hydrochloride; Methanesulfonamide, N-(4-(1-Hydroxy-2-((1-Methylethyl)Amino)Ethyl)Phenyl)-, Monohydrochloride; N-(4-{1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl}Phenyl)Methanesulfonamide Hydrochloride; N-{4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl}Methanesulfonamide Hydrochloride; Sotalol Hydrochloride 100 Microg/mL in Acetonitrile; Methanesulfonanilide, 4'-(1-Hydroxy-2-(Isopropylamino)Ethyl)-, Monohydrochloride; N-(2-Hydroxy-2-{4-[(Methylsulfonyl)Amino]Phenyl}Ethyl)Propan-2-Aminium Chloride; N-[4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Monohydrochloride; Methanesulfonanilide, 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]-, Monohydrochloride; N-(4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl)Methanesulfonamide Hydrochloride; N-[4-[1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl]Phenyl]Methanesulfonamide Hydrochloride; N-{4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl}Methanesulfonamide Hydrochloride; Methanesulfonamide, N-[4-[1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl]Phenyl]-, Monohydrochloride; Sorine (TN); (y)-Sotalol Hydrochloride; (?)-Sotalol Hydrochloride; Sotalol Hydrochloride- Bio-X; ( Inverted Question mark)-Sotalol Hydrochloride; Sotylize Component Sotalol Hydrochloride; (+/-)-Sotalol Hydrochloride, Analytical Standard; Sotalol Hydrochloride Component OF Sotylize; (+/-)-Sotalol Hydrochloride, >=98% (TLC), Powder; Methanesulphone, 4'-(1-Hydroxy-2-Isopropylaminoethyl)-; Sotalol Hydrochloride 1.0 mg/ml in Methanol (as free base); [(Isopropylamino)Hydroxyethyl]Methanesulfonanilide Hydrochloride; 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Hydrochloride; 4'-[2-(Isopropylamino)-1-Hydroxyethyl]Methanesulfonanilide Hydrochloride; 4'-[2-(Isopropylamino)-1-Hydroxyethyl]Methanesulfonanilide Monohydrochloride; 4-[2-(Isopropylamine)-1-Hydroxyethyl]Methanesulfonanilide Hydrochloride; N-Isopropyl-.beta.-(4-Methanesulfonamidophenyl)Ethanolamine Hydrochloride; p-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Hydrochloride; Sotalol Hydrochloride, United States Pharmacopeia (USP) Reference Standard; Metanosulfonamida, N-[4-[1-Hidroxi-2-[(1-Metiletil)Amino]etil]Fenil]-, Clorhidrato (1:1); N-(4-{1-Hydroxy-2-[(Propan-2-yl)Amino]Ethyl}Phenyl)Methanesulfonamide Hydrochloride; N-[4-[1-Oxidanyl-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; Methanesulfonamide, N-(4-(1-Hydroxy-2-((1-Methylethyl)Amino)Ethyl)Phenyl)-, Hydrochloride (1:1); Methanesulfonamide, N-[4-[1-Hydroxy-2-[(1-Methylethyl) Amino]Ethyl]Phenyl]-, Monohydrochloride
Brief Introduction
This product is β Receptor blockers β The blocking effect of receptor is weaker than that of propranolol (Propranolol), about 1/3 of propranolol; The local anesthetic effect and "Quinidine like" effect are only 1/300 of propranolol. Its antiarrhythmic effect is caused by prolonging the time of Action potential, and has nothing to do with the local anesthetic effect. This product is easy to be absorbed orally, has a rapid effect, has little inhibition on myocardium, and is safe and effective. It is clinically used to treat arrhythmia caused by multiple reasons, especially atrial and ventricular premature beats, and can also be used for sinus and supraventricular tachycardia, Atrial fibrillation, etc; It can also be used for angina pectoris to reduce the number of attacks and the amount of Nitroglycerin, and improve exercise tolerance; It can also be used for congestive heart failure and hypertension. This product has minimal toxic side effects and may cause bradycardia, but it does not exacerbate congestive heart failure
CAS:98048-97-6
Molecular Formula:C30H46NO7P
4-Cyclohexyl-1-[2-[(2-Methyl-1-Propanoyloxy-Propoxy)-(4-Phenylbutyl)Phosphoryl]Acetyl]; Fosinopril,(4S)-4-Cyclohexyl-1-[(Rs)-2-Methyl-1-(Propionyloxy)Propoxy]-(4-Phenylbutyl)Phosphinylacetyl-L-Proline; L-Proline, 4-Cyclohexyl-1-(R)-(1S)-2-Methyl-1-(1-Oxopropoxy)Propoxy(4-Phenylbutyl)Phosphinylacetyl-, (4S)-; Fosenopril; [1[S^^ (R^^)],2α,4β]-4-Cyclohexyl-1-[[[2-Methyl-1-(1-Oxopropoxy)-Propoxy](4-Phenylbutyl)Phosphinyl]Acetyl]-L-Proline; Secorvas; Sq-28555; Staril
Brief Introduction
1. Mild, moderate and severe hypertension: it can be used as the first choice medicine and when other antihypertensive drugs are ineffective. 2. Myocardial ischemia: it can reduce myocardial oxygen consumption, increase myocardial oxygen supply, Bi directionally treat myocardial ischemia, reduce the number of angina attacks and the amount of nitrates. 3. Treatment of heart failure: it plays a role by dilating blood vessels and reducing water and sodium retention, and can be used as the first choice medicine.
CAS:64679-65-8
Molecular Formula:C5H7N3O2S
[(3-Methyl-1H-1,2,4-Triazol-5-yl)thio]Acetic acid; 5-Methyl-1H-1,2,4-Triazol-s-yl)thio}-Acetic acid; Tiazotic acid; (5-Methyl-1H-[1,2,4]Triazol-3-Ylmercapto)-Essigsaeure; 2-(5-Methyl-2H-1,2,4-Triazol-3-Ylthio)Acetic acid; [(5-Methyl-1H-1,2,4-Triazol-3-yl)thio]Acetic acid(Saltdata: FREE); (5-Methyl-1H-[1,2,4]Triazol-3-Ylmercapto)-Acetic acid; 2-(5-Methyl-1H-1,2,4-Triazol-3-Ylthio)Aceticacid
Brief Introduction
Cardio cerebrovascular agents
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >